Structural genomics and drug discovery for infectious diseases

Area of Science:

• Structural biology
• Infectious disease research

Background:

• Structural genomics is crucial for identifying drug targets in infectious disease pathogens.
• Numerous global projects focus on pathogen structural genomics.

Purpose of the Study:

• Establish the Center for Structural Genomics of Infectious Diseases (CSGID).
• Utilize high-throughput structural biology to characterize pathogen proteins.
• Prioritize targets with significant biomedical potential, including drug targets, virulence factors, and vaccine candidates.

Main Methods:

• Employ state-of-the-art, high-throughput structural biology techniques.
• Focus on proteins from NIAID Category A-C pathogens and emerging/re-emerging infectious diseases.
• Primarily use X-ray crystallography for rapid, cost-effective structure determination.
• Leverage synchrotron X-ray sources for high-throughput crystallographic structure determination.

Main Results:

• CSGID aims to determine 400 protein and protein-ligand complex crystal structures.
• The project will generate a publicly accessible library of protein structures.
• These structures will serve as a foundation for structure-aided drug discovery.

Conclusions:

• Structural genomics is vital for advancing infectious disease research.
• CSGID's efforts will significantly contribute to the drug discovery pipeline for infectious diseases.
• The generated structural data will empower the scientific community in developing novel therapeutics.